Mydacla (Daclatasvir Dihydrochloride) is a treatment for chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection. It is prescribed with sofosbuvir, and with or without ribavirin.
Dosage and Administration
The recommended dosage in most people is one 60mg tablet taken each day. The tablet is taken orally and should be swallowed whole with a glass of water. It can be taken with or without food.
Treatment with Mydacla (Daclatasvir Dihydrochloride) is usually prescribed for a period of 12 weeks.
Mydacla should always be taken concurrently with Sofosbuvir.